148 related articles for article (PubMed ID: 15713387)
1. Novel and orally bioavailable inducible nitric oxide synthase inhibitors: synthesis and evaluation of optically active 4,5-dialkyl-2-iminoselenazolidine derivatives.
Ueda S; Terauchi H; Suzuki K; Yano A; Matsumoto M; Kubo T; Minato H; Arai Y; Tsuji J; Watanabe N
Bioorg Med Chem Lett; 2005 Mar; 15(5):1361-6. PubMed ID: 15713387
[TBL] [Abstract][Full Text] [Related]
2. 4,5-dialkylsubstituted 2-imino-1,3-thiazolidine derivatives as potent inducible nitric oxide synthase inhibitors.
Ueda S; Terauchi H; Yano A; Matsumoto M; Kubo T; Kyoya Y; Suzuki K; Ido M; Kawasaki M
Bioorg Med Chem; 2004 Aug; 12(15):4101-16. PubMed ID: 15246088
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
Ichimori K; Stuehr DJ; Atkinson RN; King SB
J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase.
Jackson SA; Sahni S; Lee L; Luo Y; Nieduzak TR; Liang G; Chiang Y; Collar N; Fink D; He W; Laoui A; Merrill J; Boffey R; Crackett P; Rees B; Wong M; Guilloteau JP; Mathieu M; Rebello SS
Bioorg Med Chem; 2005 Apr; 13(8):2723-39. PubMed ID: 15781384
[TBL] [Abstract][Full Text] [Related]
5. Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors.
López Cara LC; Camacho ME; Carrión MD; Tapias V; Gallo MA; Escames G; Acuña-Castroviejo D; Espinosa A; Entrena A
Eur J Med Chem; 2009 Jun; 44(6):2655-66. PubMed ID: 19117642
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 3-benzyl-1-methyl- and 1-methyl-3-phenyl-isothioureas as potential inhibitors of iNOS.
Paesano N; Marzocco S; Vicidomini C; Saturnino C; Autore G; De Martino G; Sbardella G
Bioorg Med Chem Lett; 2005 Feb; 15(3):539-43. PubMed ID: 15664809
[TBL] [Abstract][Full Text] [Related]
7. KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerization.
Symons KT; Massari ME; Nguyen PM; Lee TT; Roppe J; Bonnefous C; Payne JE; Smith ND; Noble SA; Sablad M; Rozenkrants N; Zhang Y; Rao TS; Shiau AK; Hassig CA
Mol Pharmacol; 2009 Jul; 76(1):153-62. PubMed ID: 19364813
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of pyrido[1,2-a]pyrimidines as inhibitors of nitric oxide synthases.
Bluhm U; Boucher JL; Buss U; Clement B; Friedrich F; Girreser U; Heber D; Lam T; Lepoivre M; Rostaie-Gerylow M; Wolschendorf U
Eur J Med Chem; 2009 Jul; 44(7):2877-87. PubMed ID: 19144449
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: synthesis and biological evaluation of dihydropyridin-2-imines.
Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Nakai H; Toda M
Bioorg Med Chem Lett; 2002 Sep; 12(17):2291-4. PubMed ID: 12161118
[TBL] [Abstract][Full Text] [Related]
10. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R
Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957
[TBL] [Abstract][Full Text] [Related]
11. Conformationally constrained NO synthase inhibitors: rigid analogs of L-N-iminoethylornithine.
Eustache J; Grob A; Lam C; Sellier O; Schulz G
Bioorg Med Chem Lett; 1998 Nov; 8(21):2961-6. PubMed ID: 9873655
[TBL] [Abstract][Full Text] [Related]
12. 1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
Tinker AC; Beaton HG; Boughton-Smith N; Cook TR; Cooper SL; Fraser-Rae L; Hallam K; Hamley P; McInally T; Nicholls DJ; Pimm AD; Wallace AV
J Med Chem; 2003 Mar; 46(6):913-6. PubMed ID: 12620067
[TBL] [Abstract][Full Text] [Related]
13. Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III).
Carrión MD; López Cara LC; Camacho ME; Tapias V; Escames G; Acuña-Castroviejo D; Espinosa A; Gallo MA; Entrena A
Eur J Med Chem; 2008 Nov; 43(11):2579-91. PubMed ID: 18325637
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. synthesis and biological evaluation of dihydropyridin-2(1H)-imines and 1,5,6,7-tetrahydro-2H-azepin-2-imines.
Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Nishizaki M; Naka M; Komeno M; Nakai H; Toda M
Bioorg Med Chem; 2003 Mar; 11(5):689-702. PubMed ID: 12537998
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structural investigations and biological evaluation of novel hexahydropyridazine-1-carboximidamides, -carbothioamides and -carbothioimidic acid esters as inducible nitric oxide synthase inhibitors.
Morgenstern O; Wanka H; Röser I; Steveling A; Kuttler B
Bioorg Med Chem; 2004 Mar; 12(5):1071-89. PubMed ID: 14980620
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of indazole derivatives.
Claramunt RM; López C; López A; Pérez-Medina C; Pérez-Torralba M; Alkorta I; Elguero J; Escames G; Acuña-Castroviejo D
Eur J Med Chem; 2011 Apr; 46(4):1439-47. PubMed ID: 21334118
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological testing of potential heme-coordinating nitric oxide synthase inhibitors.
Litzinger EA; Martásek P; Roman LJ; Silverman RB
Bioorg Med Chem; 2006 May; 14(9):3185-98. PubMed ID: 16431112
[TBL] [Abstract][Full Text] [Related]
18. 1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence.
López-Cara LC; Carrión MD; Entrena A; Gallo MA; Espinosa A; López A; Escames G; Acuña-Castroviejo D; Camacho ME
Eur J Med Chem; 2012 Apr; 50():129-39. PubMed ID: 22336385
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation, and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase.
Maccallini C; Patruno A; Besker N; Alì JI; Ammazzalorso A; De Filippis B; Franceschelli S; Giampietro L; Pesce M; Reale M; Tricca ML; Re N; Felaco M; Amoroso R
J Med Chem; 2009 Mar; 52(5):1481-5. PubMed ID: 19203270
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 3-substituted arginine analogs as selective inhibitors of human nitric oxide synthase isozymes.
Ijuin R; Umezawa N; Nagai S; Higuchi T
Bioorg Med Chem Lett; 2005 Jun; 15(11):2881-5. PubMed ID: 15911272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
